disease 2,677 words KG: ent-dise-b70d8e33
Contents

C9orf72 Repeat Expansion in ALS

Disease Info
Endosomal traffickingProper sorting and transport of vesicles within cells
Lysosomal functionDegradation and recycling of cellular components
Neuronal transportMovement of organelles and signaling complexes along axons
Synaptic vesicle dynamicsRegulating neurotransmitter release at presynaptic terminals
SRSF2 and other splicing factorsLeading to widespread alternative splicing defects
Pur alphaA multi-functional RNA-binding protein critical for RNA transport
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (42)

Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.78
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.78
Circadian Clock-Autophagy Synchronization
Score: 0.76
Senescence-Activated NAD+ Depletion Rescue
Score: 0.76
Circadian-Synchronized Proteostasis Enhancement
Score: 0.74
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73
Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.72
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Complement C1q Mimetic Decoy Therapy
Score: 0.69
Extracellular Matrix Stiffness Modulation
Score: 0.69
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.68
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.67
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.66
pg 1/3Next →

Related Analyses (29)

RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived

Related Experiments (22)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.